Quantum BioPharma (NASDAQ: QNTM) announced compelling results from a clinical trial evaluating its dietary supplement, unbuzzd. The double-blind, randomized, placebo-controlled study demonstrated that unbuzzd significantly accelerates alcohol metabolism, lowers blood alcohol concentration (BAC), and reduces symptoms of intoxication and hangovers. Participants in the trial, aged 21 to 43, experienced a rapid reduction in BAC—more than […]